Entelexo Biotherapeutics
Entelexo has created a novel platform technology for engineering exosomes as a new approach to treating diseases.
2 employees · est. 2020 · Irvine, United States
Ensoma is the older company (2019 vs 2020); Ensoma is the larger of the two.
Side-by-Side Comparison
| Metric | Ensoma | Entelexo Biotherapeutics |
|---|---|---|
| Founded | ||
| Founded | 2019 older | 2020 |
| Headquarters | ||
| Headquarters | Boston, United States | Irvine, United States |
| Employees | ||
| Employees | 51 larger | 2 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Unknown | Unknown |
| Total Funding | ||
| Total Funding | $258.00M | $130.00K |
| Funding Rounds | ||
| Funding Rounds | 5 | 1 |
| Services | ||
| Services | In Vivo Hematopoietic Stem Cell Engineering, Gene Therapy Development, Delivery System for Genetic Modifications | Development of exosome-based therapeutics, Prototyping therapeutics for autoimmune diseases, Engineering exosomes for targeted cell communication |
| Target Customers | ||
| Target Customers | Patients with Hematologic Disorders, Healthcare Providers, Pharmaceutical Researchers, Biotech Investors | Patients with autoimmune diseases, Healthcare professionals specializing in autoimmune disorders, Biotech and pharmaceutical companies |
| Taxonomy | ||
| Taxonomy | Genomic Medicine, In Vivo Treatments, Gene Modification, Immune Cell Engineering, Blood Cell Engineering, Engenious Vectors, Next-generation Therapies, One-time Treatments, Non-myeloablative Conditioning, Outpatient Healthcare, Off-the-shelf Biologics, Rare Disease Treatment, Precision Medicine, Genetic Engineering | Exosome Engineering, Biotherapeutics, Immune-mediated Diseases, Extracellular Vesicles, Stem Cell Derivatives, Autoimmune Diseases, Novel Treatments, Disease Pathology, Rational Engineering Platform, Indication-specific Treatments, Cellular Engineering, Pharmaceuticals, Therapeutics, Drug Development |
| Website | ||
| Website | ensoma.com | entelexo.com |
About Ensoma
Ensoma, established in 2019, is pioneering a transformative approach in the Biotechnology, Health and Wellness, and Life Sciences sectors. Operating from the United States, Ensoma focuses on developing one-time in vivo treatments that aim to precisely engineer blood and immune cells to combat diseas...
About Entelexo Biotherapeutics
Entelexo Biotherapeutics is pioneering a cutting-edge platform technology centered around the engineering of exosomes, positioning itself as an innovator in the medical treatment landscape. Their slogan, "Entelexo has created a novel platform technology for engineering exosomes as a new approach to...
We will tell you when either one moves
BounceWatch watches Ensoma and Entelexo Biotherapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Ensoma and Entelexo Biotherapeuti... — by email.
Frequently Asked Questions
Compare Ensoma with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Ensoma on 9 Jun 2026, and Entelexo Biotherapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
